By TX Investment Consulting Co., Ltd.
- Feb 16, 2011
- Pharmaceuticals
Take example of WTO, China’s essential drug system takes accessibility as the most important goal. This round of healthcare reform begins from April 2009 and its goal is to establish a fundamental healthcare system covering all urban and rural citizens of China by 2020. Its core is to set up four significant systems in public .......
By China Galaxy Securities Co.Ltd.
- Mar 1, 2010
Event:
The company announced in the evening of Jan 29, 2010: After preliminary estimation and calculation by finance department, the company’s accumulated actual net profit is ~Rmb195mn-215mn in 2009, and net profit attribute to owners of parent company sees year-on-year growth of ~67%-84%.
Our Analysis and Estimation:
1. Performance is beyond universal market anticipation.
Market estimation on the company’s .......
By TX Investment Consulting Co., Ltd.
- Apr 27, 2009
- Northeast Pharmaceutical Group Co., Ltd.
The company released its Q1 2009 report, according to which it realized business turnover of Rmb1396mn (+25.10% yoy), net profit attributable to parent of Rmb157mn (+433.77% yoy), and EPS of Rmb0.471.
We hereby maintain its earning forecast in 2009-2010E EPS to be Rmb1.70 and Rmb2.05, representing dynamic P/E ratio at 12x and 10x based on closing .......
By TX Investment Consulting Co., Ltd.
- Apr 24, 2009
- Nanjing Medical Company Limited
As shown in Q1 2009 report, during the period under view, it realized business turnover of Rmb2804mn (+2.81% yoy), operating profit of Rmb18.64mn (+1.81% yoy), net profit attributable to parent of Rmb10.24mn (+0.55% yoy), and basic EPS of Rmb0.041.
Earning forecast and rating: We predict its 2009-2010E EPS to be Rmb0.20 and Rmb0.28, representing dynamic .......
By TX Investment Consulting Co., Ltd.
- Apr 22, 2009
The company issued its Q1 2009 report, according to which it realized operating revenue of Rmb123mn (+41.59% yoy), operating profit of Rmb24.71mn (+61.60% yoy), net profit attributable to parent of Rmb20.94mn (+88.73% yoy) and basic EPS of Rmb0.20. In addition, the company forecasted its net profit attributable to parent to see over 50% surge in .......
By TX Investment Consulting Co., Ltd.
- Apr 22, 2009
- Tianjin Tianyao Pharmaceutical Co., Ltd.
In Q1 2009, the company reported operating revenue of Rmb211mn (+6.6% yoy or -3.3% qoq), operating profit of Rmb11.07mn (+3.5% yoy or +79.0% qoq), net profit attributable to parent of Rmb9.66mn (+13.4% yoy or -0.9% qoq) and basic EPS of Rmb0.018.
Earning forecast and rating: We maintain our forecast of the company and predict its 2009-2010E .......
By TX Investment Consulting Co., Ltd.
- Apr 21, 2009
- Zhejiang Hisun Pharmaceutical Co., Ltd.
In the first quarter of 2009, the company reported business turnover of Rmb851mn (+9.46% yoy or +5.56% mom), operating profit of Rmb56.55mn (-6.85% yoy or -0.13% mom), net profit attributable to parent of Rmb49.42mn (+10.88% yoy or -16.46% mom), and basic EPS of Rmb0.11.
Earning forecast and rating: Earning forecast is hereby maintained. Its 2009-2010E .......
By TX Investment Consulting Co., Ltd.
- Apr 21, 2009
- Wuhan Jianmin Pharmaceutical Groups Co., Ltd.
According to the company’s 2008 annual report, during the period under view, it realized business turnover of Rmb835mn (-19.38% yoy), total profit of Rmb24.62mn (+16.31% yoy), net profit attributable to parent of Rmb15.78mn (+89.5% yoy), net profit of Rmb-8.15mn if nonrecurring profit & loss deducted, and EPS of Rmb0.1. The company’s dividend distribution plan in .......
By TX Investment Consulting Co., Ltd.
- Apr 13, 2009
- North China Pharmaceutical Co., Ltd.
The company issued its 2008 annual report, according to which it realized business turnover of Rmb4911mn (+15.81% yoy), total profit of Rmb408mn (+182.91% yoy), net profit attributable to parent of Rmb269mn (+344.50% yoy), and EPS of Rmb0.26. It planned no profit distribution proposal in 2008.
We maintain its 2009-2010E EPS to be Rmb0.30 and Rmb0.35, .......
By TX Investment Consulting Co., Ltd.
- Mar 27, 2009
- Angel Yeast Co., Ltd.
In 2008, the company reported business turnover of Rmb1311mn (+23.61% yoy), operating profit of Rmb145mn (+24.70% yoy), net profit attributable to parent of Rmb105mn (+15.25% yoy), and basic EPS of Rmb0.385. The company’s dividend distribution plan was to send pretax cash of Rmb1.30 for every ten shares.
Earning forecast and rating: Supposing that domestic business .......